Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-01

Study Completion Date

2023-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Infertility was reported in approximately 15% of all heterozygous couples, with male factor accounting for nearly half the cases. This typically occurs due to low sperm production, sperm dysfunction, and sperm delivery obstruction. Etiology of male infertility can be attributed to many factors including acute or chronic illness, accidents, and lifestyle choices.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sperms Activation by Direct Electrical Shocks on Testis in Infertile Males

NCT04173052

Infertility

COMPLETED NA

Intra Testicular Artery Injection of Bone Marrow Stem Cell in Management of Azoospermia

NCT02008799

Azoospermia

UNKNOWN NA

Management of Non Obstructive Azoospermia in Men

NCT06983626

Male Infertility Azoospermia, Nonobstructive

COMPLETED NA

Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy

NCT05110391

Non-obstructive Azoospermia Hormone Deficiency Hypogonadism, Male +1 more

COMPLETED

The Effect of Low Electrical Current on Testicular Spermatocyte Count

NCT02617173

Oligozoospermia Azoospermia

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study demonstrated that using a painless, convenient at-home device could significantly improve sperm motility and count. This device can be utilized to tackle (for unexplained infertility) the significant issue of infertility in a cost-effective, safe and efficacious.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility, Male Infertility Unexplained Infertility Due to Complete Spermatogenic Arrest Oligospermia Asthenozoospermia Necrospermia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Double blinded two groups, one is the treated group and the other is the placebo group.

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

By mixing the devices together and giving them to the participants blindly.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Testes shocker

This device is working and giving the electrical shocks regularly.

Group Type ACTIVE_COMPARATOR

Testes shocker

Intervention Type DEVICE

It is a device that give electric shocks (up to 5 milli Amperes) and it is designed to contain both the testes within it.

Fake Testes shocker

This device is not giving electricity but it is working with a red light, so the participants cannot suspect it.

Group Type PLACEBO_COMPARATOR

Testes shocker

Intervention Type DEVICE

It is a device that give electric shocks (up to 5 milli Amperes) and it is designed to contain both the testes within it.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Testes shocker

It is a device that give electric shocks (up to 5 milli Amperes) and it is designed to contain both the testes within it.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infertile male with oligosperma, necrospermia, asthenozoospermia or hypospermia. Must not taking any drugs or medications for infertility and has nit any congenital diseases in the genital tracts or chronic diseases.

Exclusion Criteria

* Have congenial genital tract disease, has a chrome disease, has other than the above mentioned causes for infertility or taking medications that can affect the fertility.

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes